HYDRA-ZIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Hydra-zide, and what generic alternatives are available?
Hydra-zide is a drug marketed by Strides Pharma Intl and is included in three NDAs.
The generic ingredient in HYDRA-ZIDE is hydralazine hydrochloride; hydrochlorothiazide. There are twenty-one drug master file entries for this compound. Additional details are available on the hydralazine hydrochloride; hydrochlorothiazide profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for HYDRA-ZIDE?
- What are the global sales for HYDRA-ZIDE?
- What is Average Wholesale Price for HYDRA-ZIDE?
Summary for HYDRA-ZIDE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 3 |
| DailyMed Link: | HYDRA-ZIDE at DailyMed |
US Patents and Regulatory Information for HYDRA-ZIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Strides Pharma Intl | HYDRA-ZIDE | hydralazine hydrochloride; hydrochlorothiazide | CAPSULE;ORAL | 088957-001 | Oct 21, 1985 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Strides Pharma Intl | HYDRA-ZIDE | hydralazine hydrochloride; hydrochlorothiazide | CAPSULE;ORAL | 088946-001 | Oct 21, 1985 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Strides Pharma Intl | HYDRA-ZIDE | hydralazine hydrochloride; hydrochlorothiazide | CAPSULE;ORAL | 088961-001 | Oct 21, 1985 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
